Cyclic nucleotides and gluconeogenesis by rat liver cells

Area of Science:

• Hepatocyte metabolism
• Endocrinology
• Cellular signaling

Background:

• Gluconeogenesis is a vital metabolic process for maintaining blood glucose levels.
• Hormonal regulation of gluconeogenesis by glucagon and epinephrine is well-established but involves complex signaling pathways.
• Understanding these pathways is crucial for metabolic disease research.

Purpose of the Study:

• To investigate the distinct signaling mechanisms of glucagon and epinephrine in regulating gluconeogenesis in rat hepatocytes.
• To elucidate the roles of cyclic AMP (cAMP), cyclic GMP (cGMP), and calcium (Ca2+) in these hormonal responses.

Main Methods:

• Isolated rat hepatocytes were used to measure gluconeogenesis rates from various substrates.
• Hormonal stimulation (glucagon, epinephrine, isoproterenol, phenylephrine) and the effects of signaling molecules (dibutyryl cAMP, cGMP, carbamylcholine) were assessed.
• Inhibition studies involved manipulating extracellular calcium, using ion channel blockers (D-600, tetracaine), and specific inhibitors (propranolol, dihydroergotamine).

Main Results:

• Both glucagon and epinephrine stimulated gluconeogenesis and cAMP accumulation.
• Epinephrine's effect was independent of cAMP but sensitive to alpha-adrenergic blockers, suggesting a distinct pathway.
• Calcium removal or blockers inhibited basal and stimulated gluconeogenesis, while cGMP and other agents inhibited hormone-stimulated but not basal rates.

Conclusions:

• Glucagon likely activates gluconeogenesis via a cAMP-dependent pathway.
• Epinephrine activates gluconeogenesis through a cAMP-independent mechanism, not involving cGMP, Ca2+, or K+ flux.
• Extracellular calcium plays a critical role in both basal and hormone-stimulated gluconeogenesis.